Nitric Oxide

CAS 10102-43-9 3 current recordsSmall Molecule

Who holds supplier records for Nitric Oxide? 3 organisations hold a current record for Nitric Oxide: an active US FDA Type II Drug Master File or a CEP. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: United States (1), Sweden (1) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Nitric Oxide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nitric-oxide

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Nitric Oxide expires 22 Jul 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nitric Oxide. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • AIRGAS THERAPEUTICS LLC
    Active DMF 24763 · latest filing Mar 2011
    United States
  • LINDE HEALTHCARE AB
    Valid CEP holder (EDQM); not necessarily the manufacturer
    SwedenCEP
  • SOL S.P.A.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ItalyCEP
Need Nitric Oxide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Nitric Oxide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
LINDE HEALTHCARE AB SolnaSE
R1-CEP 2016-217 - Rev 00
Nitric oxide
Sept 2022—
SOL S.P.A. MonzaIT
R1-CEP 2014-103 - Rev 00
Nitric oxide
May 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (5 listed products contain Nitric Oxide). The latest listed patent expires 22 Jul 2040. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Nitric Oxide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200689).

Chemical identity

IUPAC name
nitric oxide
Canonical SMILES
[N]=O
InChIKey
MWUXSHHQAYIFBG-UHFFFAOYSA-N
Synonyms
Amidogen, oxo-, Genosyl, Inomax, Inovent, Nitric oxide, Nitric oxide trimer, Nitrogen oxide (no), Nitrosyl radical, OHM-11771, nitrogen monoxide, Mononitrogen monoxide, nitrogen monooxide

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Vasodilator
Physiologic effect
Vasodilation

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nitric Oxide?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Nitric Oxide: AIRGAS THERAPEUTICS LLC (United States), LINDE HEALTHCARE AB (Sweden) and SOL S.P.A. (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nitric Oxide Drug Master Files are active?

AIRGAS THERAPEUTICS LLC (DMF 24763). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Nitric Oxide have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Nitric Oxide on the EDQM register, including LINDE HEALTHCARE AB Solna (SE) and SOL S.P.A. Monza (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Nitric Oxide?

Yes. The latest patent listed for an approved US product containing Nitric Oxide expires 22 Jul 2040, across 5 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Nitric Oxide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nitric Oxide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.